In this episode of Ask the Innovators, Jim Jorgenson sits down with Visante’s Angela De Ianni, Managing Director, and Nivedha Poondi, Consultant, to unpack the rapid changes happening across the 340B program. From the transition to a rebate model to the ongoing challenges around DSH eligibility, our guests break down what these shifts mean for covered entities and share practical advice on how hospitals and health systems can prepare, adapt, and stay resilient. Tune in to hear expert insights on the future of 340B—and the strategies organizations can use to remain grounded and strategic in the face of uncertainty.

In this episode of Pharmacy Innovators, host Jim Jorgenson sits down with longtime friend and colleague Dr. Dawn Moore, Vice President of Pharmacy at Community Health Network in Indiana. With a career grounded in both strategy and service, Dawn shares her journey through health system leadership, her approach to ambulatory pharmacy growth, and the ways she's navigated competitive pressures in specialty and infusion care.

The conversation dives into how Community Health Network is addressing system-wide priorities, the importance of partnering strategically in pharmacy services, and how strong leadership can drive sustainable outcomes. Dawn also reflects on her run for the ASHP Board of Directors, her advocacy for women in pharmacy leadership, and how she balances a demanding career with raising a family.

Whether you're a pharmacy leader, health system executive, or aspiring professional, this episode is packed with practical insights, inspiration, and strategic takeaways.

In this episode of The Innovators Podcast, host Jim Jorgenson is joined by pharmacy revenue cycle experts Maxie Friemel and Tim Miller to explore the often underestimated, and increasingly critical, world of pharmacy finances. The conversation goes well beyond billing, diving into key issues such as prior authorizations, denials, biosimilar adoption, charge structures, and payer audits.

For hospital and health system leaders, the pharmacy revenue cycle presents both significant risk and opportunity. As specialty drug costs rise and payer scrutiny intensifies, understanding pharmacy’s role in financial performance is more important than ever. Maxie and Tim share practical insights to help leaders foster collaboration across pharmacy, finance, compliance, and IT, improve charge capture, and drive clean claims.

Packed with actionable strategies and big-picture thinking, this is a must-listen episode for any hospital leader focused on strengthening financial sustainability and operational alignment.

In this episode, host Jim Jorgenson sits down with returning guest Dr. Alex Varkey to discuss big changes—both personal and professional. Since his last appearance, Alex has completed his term as President of the American Pharmacists Association (APhA) and made a major career move, leaving a successful role in health-system leadership to join Visante.

Alex shares what motivated his transition, what it’s been like stepping into the consulting world, and what lessons he’s bringing with him from his time at APhA. He also offers thoughtful advice for professionals considering a change and discusses the trends he believes will shape the next five years in pharmacy.

From workforce dynamics to innovation in care delivery, this conversation is packed with leadership insight and forward-thinking perspectives for anyone invested in the future of pharmacy.

In this episode of the Pharmacy Innovators Podcast, host Jim Jorgenson is joined by two powerhouse voices in the 340B space: Kristin Fox Smith, Visante’s own 340B expert, and Ted Slafsky, Publisher & CEO of the 340B Report.

Together, they dive into the latest political and regulatory shifts shaking the 340B landscape — from new Congressional leadership and pending legislation to the major reorganization of HHS and HRSA. The episode also explores Medicaid trends, judicial developments, contract pharmacy access, and the broader political forces shaping healthcare access for vulnerable populations.

Whether you’re a healthcare leader, policymaker, or 340B stakeholder, this episode offers timely and valuable insights into the evolving landscape of the program.

340B Report website: https://340breport.com/ Subscribe now using coupon code VISANTE25

In this episode, host Jim Jorgenson talks with Dr. Brianne Bakken, PharmD, MHA, Associate Professor at The University of Iowa College of Nursing, about the National Pharmacist Workforce Study (NPWS) and its impact on pharmacy. They explore key findings on burnout, job satisfaction, and staffing shortages, as well as how AI, telepharmacy, and policy changes are reshaping the profession.

Dr. Bakken discusses her award-winning 2019 paper on discrimination and harassment in pharmacy and offers a preview of the 2024 NPWS. She also highlights strategies like leadership training, inclusion initiatives, and resilience programs that are helping pharmacies adapt and thrive.

Link to NPWS final reports: https://www.aacp.org/article/national-pharmacist-workforce-studies

NPWS is funded by the Pharmacy Workforce Center

In this episode of the Pharmacy Innovators Podcast, Visante CEO Steve Rough and President Phil Brummond dive into Visante’s Top Ten Issues Facing Health System Pharmacy in 2025. This insightful discussion covers key topics such as alternative payment models, revenue cycle optimization, centralized medication access, and more—critical areas shaping the future of pharmacy practice.

Join them as they explore how to advocate for essential resources, the expanding role of pharmacy services in health system strategy, and major healthcare marketplace changes that could impact your organization.

Don’t miss this episode for expert insights and strategies to enhance financial and operational performance in 2025 and beyond!

In this episode, we address audience-submitted questions about the 340B Program with Kristin Fox Smith and Sean Hall, two leading experts from Visante. Topics range from potential legislative changes and manufacturer rebate models to operational challenges and future program expectations. Whether you’re a healthcare professional or simply curious about the 340B Program, this episode offers valuable insights into the evolving landscape of this critical initiative.